These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7147357)

  • 61. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of esophageal cancer with vindesine: an open trial.
    Bezwoda WR; Derman DP; Weaving A; Nissenbaum M
    Cancer Treat Rep; 1984 May; 68(5):783-5. PubMed ID: 6722833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 64. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
    Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L
    Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
    Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
    J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A randomized study of continuous infusion vindesine versus vinblastine in adults with refractory metastatic sarcomas.
    Yap BS; Benjamin RS; Plager C; Burgess MA; Papadoupoulos N; Bodey GP
    Am J Clin Oncol; 1983 Apr; 6(2):235-8. PubMed ID: 6829497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.
    Gralla RJ; Raphael BG; Golbey RB; Young CW
    Cancer Treat Rep; 1979 Aug; 63(8):1343-6. PubMed ID: 225028
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of vindesine and MER in colorectal cancer.
    Bedikian AY; Valdivieso M; Maroun J; Gutterman JU; Hersh EM; Bodey GP
    Cancer; 1980 Aug; 46(3):463-7. PubMed ID: 6249481
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP; Bains M; Chapman R; Golbey R
    Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Continuous vindesine infusion in advanced head and neck cancer.
    Popkin JD; Bromer RH; Vaughan CW; Byrne RE; Licciardello JT; Hoffer SM; Welch JM; Fofonoff SA; Strong MS; Hong WK
    Am J Clin Oncol; 1983 Jun; 6(3):301-4. PubMed ID: 6846248
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 74. Phase I study of vintriptol, a tryptophan ester of vinblastine.
    Oosterkamp HM; Vlasveld LT; Wanders J; Beijnen JH; van Tellingen O; Dubbelman AC; Simonetti GP; Franklin HR; Vermorken JB; Ten Bokkel Huinink WW
    Eur J Cancer; 1991; 27(10):1222-6. PubMed ID: 1835590
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Phase II study of Vindesine in patients with hematological malignancy].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative Group.
    Paridaens R; Clarysse A; Rozencweig M; Rotmensz N; Heuson JC
    Eur J Cancer Clin Oncol; 1985 May; 21(5):595-9. PubMed ID: 4040025
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
    Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.
    Pazdur R; Rossof AH; Chandra G; Bonomi PD; Slayton RE; Wolter J
    Cancer Chemother Pharmacol; 1982; 9(1):41-4. PubMed ID: 7139851
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.